| 216503-57-0 Basic information More.. |
Product Name: | Alemtuzumab | Synonyms: | Alemtuzumab;Alemtuzumab (usan/inn);Campath (tn);D02802;MabCampath;Research Grade Alemtuzumab(DHD95101) | CAS: | 216503-57-0 | MF: | | MW: | 0 | EINECS: | | Mol File: | Mol File | ![216503-57-0](/) |
Use
Alemtuzumab (Campath) is humanized MAb (Campath-1H)that is directed against the 21- to 28-kDa cell surface glycoproteinCD52. CD52 is expressed on the surface of normaland malignant B and T lymphocytes, NK cells, monocytes,macrophages, and tissues of the male reproductive system.The Campath-1H antibody is an IgG1 κ form with humanizedvariable and constant regions and CDRs from a ratMAb, Campath-1G.
Alemtuzumab is indicated for the treatment of B-cellchronic lymphocytic leukemia in patients who have beentreated with alkylating agents and who have failed on thistherapy.
- Alemtuzumab
-
- US $0.00 / kg
- 2024-04-12
- CAS:216503-57-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
|
216503-57-0
Recommend Suppliers |
|